Question NW4179 to the Minister of Health
14 December 2023 - NW4179
Clarke, Ms M to ask the Minister of Health
(a) What are the full details of all the investments that were made to the public health sector by foreign (i) governments, (ii) private companies and/or corporations and (iii) individuals in each specified financial year since 1 April 2019, (b) what is the total amount of each investment and (c) how was each investment utilised?
Reply:
a) (i),(ii),(iii) Donor funds
b) Total per each investment
|
a) (i) (ii) (iii) |
||||||
|
DONOR'S NAME |
2019/20 |
2020/21 |
2021/22 |
2022/23 |
2023/24 |
Totals |
|
b) Total: Centre for Disease Control and Prevention |
492,075,883,56 |
366,677,054,80 |
42,708,867,45 |
20,730,070,29 |
26,843,267,28 |
949,035,143,38 |
|
|
|
|
|
|
|
|
|
b) Total: European Union |
4,613,092,16 |
- |
- |
- |
- |
4,613,092,16 |
|
|
|
|
|
|
|
|
|
b) Total: Germany |
5,455,047,89 |
877 636,52 |
- |
- |
- |
6,332,684,41 |
|
|
|
|
|
|
|
|
|
b) Total: Global Fund |
616,153,230,05 |
571 301 660,14 |
1,411,879,026,50 |
922 803 142,86 |
930 804 645,72 |
4,452,941,705,27 |
(c) The Centres for Disease Control and Prevention (CDC) financial and technical support through the existing Cooperative Agreement, assists the NDoH to incorporate results of programme evaluations into operational disease prevention and control programmes.
- In Financial year 2019/2020, The CDC supported Community Services.
- In financial year 2020/2021 CDC supported procurement of HIV Pre-exposure prophylaxis drugs and TB Prevention therapy drugs. The drugs were distributed to provincial depots in 2021/2022. To date, in addition to the programmatic supports, the CDC Cooperative Agreement has been supporting the NDoH with key personnel within its directorates. Funded personnel are responsible for their respective areas of expertise, and all efforts contribute to the fight against HIV/AIDS and TB in the country. Additional funds were used to support payment of key personnel appointed in the HIV/AIDS and TB as well as Maternal Child and Women Health clusters.
END.